The effect of intermittent versus continuous dose aspirin (ASA) in current smokers on nasal epithelium gene expression

Ended Awarded Last action

Contract number
HHSN26100002
Awardee
Awarding agency
Obligated
$704,564

Award facts

Contract value 100% obligated
$704,563.99 Current and potential, with all options
Completion date 100% complete
Current and potential, with all options
NAICS code
541712 Research and Development in the Physical, Engineering, and Life Sciences (except Biotechnology)
PSC
AN12 Health R&D Services; Health Care Services; Applied Research
Set-aside
No set-aside
Competition
Full and Open Competition · 3 offers Multiple Award, Fair Opportunity
Pricing
Firm Fixed Price
Place of performance
Tucson, AZ 85719, USA

Award details come from SAM.gov/FPDS.

Transactions

Action Obligated Date
Funding Only Action P00005 -$8,863
Funding Only Action 4 -$2,450
Other Administrative Action 3 $0
Other Administrative Action 2 $0
Change Order 1 $156,835
Original award $559,042

Quick answers

Who was awarded contract HHSN26100002?

HHSN26100002 was awarded to University Of Arizona by National Cancer Institute (National Institutes of Health) on September 1, 2013.

How much is contract HHSN26100002 worth?

The government has obligated $704,564 on HHSN26100002.

Is contract HHSN26100002 an order under another contract?

Yes. HHSN26100002 is a delivery order under HHSN261201200031I, an indefinite delivery contract, on Cancer Prevention Agent Development Program 2012-2017.

Was contract HHSN26100002 competed?

The extent of competition for HHSN26100002 was full and open competition. The government received 3 offers.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award